Track Heartbeam Inc. Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Heartbeam Inc. Common Stock BEAT Open Heartbeam Inc. Common Stock in new tab

0.9524 USD
EPS
-0.56
P/B
14.85
ROE
-495.62
Beta
-0.87
Target Price
4.83 USD
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateAug. 12, 2026
EPS-0.56
Book Value0.07
Price to Book14.85
% Insiders15.363%
Estimates
Forward P/E-1.82
Forward EPS-0.53
Target Mean Price4.83

DCF Valuation

Tweak assumptions to recompute fair value for Heartbeam Inc. Common Stock (BEAT)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Heartbeam Inc. Common Stock Logo Heartbeam Inc. Common Stock Analysis (BEAT)

United States Information Technology Official Website Stock

Is Heartbeam Inc. Common Stock a good investment? Heartbeam Inc. Common Stock (BEAT) is currently trading at 0.9524 USD. Market analysts have a consensus price target of 4.83 USD. This suggests a potential upside from current levels.

Earnings Schedule: Heartbeam Inc. Common Stock is expected to release its next earnings report on Aug. 12, 2026. The market consensus estimate for Forward EPS is -0.53.

Investor FAQ

Does Heartbeam Inc. Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is Heartbeam Inc. Common Stock?

Heartbeam Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Aug. 12, 2026. The company currently has a trailing EPS of -0.56.

Company Profile

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.

Exchange Ticker
NMS (United States) BEAT

Dividends

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion